Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.

Published in: Acta diabetologica (2021)

Metformin therapy might have potential benefits for the prevention of COVID-19 among patients with type 2 DM in South Korea. However, it did not affect the hospital mortality of type 2 DM patients diagnosed with COVID-19.

Keyphrases

coronavirus disease
sars cov
ejection fraction
respiratory syndrome coronavirus
risk factors
emergency department
metabolic syndrome
cardiovascular disease
type diabetes
chronic kidney disease
coronary artery disease
adipose tissue
weight loss
skeletal muscle
electronic health record